{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:03:44Z","timestamp":1792854224096,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10528-023-10584-6","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T03:01:38Z","timestamp":1701745298000},"page":"2933-2945","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect and Mechanism of Curdione Combined with Gemcitabine on Migration and Invasion of Bladder Cancer"],"prefix":"10.1007","volume":"62","author":[{"given":"Bao-Jin","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Lei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Kamel Haithm Ali Mohammed","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Zhong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Yang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"issue":"9","key":"10584_CR1","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/mnfr.201200838","volume":"57","author":"BB Aggarwal","year":"2013","unstructured":"Aggarwal BB, Yuan W, Li S et al (2013) Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric. Mol Nutr Food Res 57(9):1529\u20131542","journal-title":"Mol Nutr Food Res"},{"key":"10584_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.lungcan.2023.01.003","volume":"176","author":"A Arunachalam","year":"2023","unstructured":"Arunachalam A, Zhang I, Zhao B et al (2023) Efficacy and safety of treatments for advanced thymic carcinoma after failure of first-line platinum-based chemotherapy: a systematic literature review and meta-analysis. Lung Cancer 176:132\u2013139","journal-title":"Lung Cancer"},{"issue":"1","key":"10584_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O et al (2022) European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in situ). Eur Urol 81(1):75\u201394","journal-title":"Eur Urol"},{"issue":"8","key":"10584_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","volume":"20","author":"TW Flaig","year":"2022","unstructured":"Flaig TW, Spiess PE, Abern M et al (2022) NCCN Guidelines(R) Insights: Bladder Cancer, Version 2.2022. J Natl Compr Cancer Netw 20(8):866\u2013878","journal-title":"J Natl Compr Cancer Netw"},{"key":"10584_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.714322","volume":"12","author":"J Gu","year":"2021","unstructured":"Gu J, Sun R, Wang Q et al (2021) Standardized Astragalus Mongholicus Bunge-Curcuma Aromatica Salisb. extract efficiently suppresses colon cancer progression through gut microbiota modification in CT26-bearing mice. Front Pharmacol 12:714322","journal-title":"Front Pharmacol"},{"issue":"2","key":"10584_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/01635581.2020.1749676","volume":"73","author":"S Hashem","year":"2021","unstructured":"Hashem S, Nisar S, Sageena G et al (2021) Therapeutic effects of curcumol in several diseases; an overview. Nutr Cancer 73(2):181\u2013195","journal-title":"Nutr Cancer"},{"issue":"40","key":"10584_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/PLPU1526","volume":"26","author":"R Heer","year":"2022","unstructured":"Heer R, Lewis R, Duncan A et al (2022) Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT. Health Technol Assess 26(40):1\u2013144","journal-title":"Health Technol Assess"},{"issue":"7","key":"10584_CR8","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.4103\/jcrt.jcrt_2187_21","volume":"18","author":"J Ji","year":"2022","unstructured":"Ji J, Yao Y, Guan F et al (2022) Efficacy and adverse reactions of intra-arterial chemotherapy in patients with bladder cancer: a systematic review and meta-analysis. J Cancer Res Ther 18(7):1884\u20131893","journal-title":"J Cancer Res Ther"},{"issue":"21","key":"10584_CR9","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.3390\/cancers13215441","volume":"13","author":"K Kaira","year":"2021","unstructured":"Kaira K, Imai H, Yamaguchi O et al (2021) Salvage chemotherapy in patients with previously treated thymic carcinoma. Cancers (Basel) 13(21):5441","journal-title":"Cancers (Basel)"},{"issue":"4 Pt 1","key":"10584_CR10","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.juro.2006.06.042","volume":"176","author":"W Kassouf","year":"2006","unstructured":"Kassouf W, Highshaw R, Nelkin GM et al (2006) Vitamins C and K3 sensitize human urothelial tumors to gemcitabine. J Urol 176(4 Pt 1):1642\u20131647","journal-title":"J Urol"},{"key":"10584_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.urology.2020.10.039","volume":"149","author":"GE Koch","year":"2021","unstructured":"Koch GE, Smelser WW, Chang SS (2021) Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them. Urology 149:11\u201320","journal-title":"Urology"},{"issue":"10271","key":"10584_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0140-6736(20)32554-X","volume":"397","author":"S Lheureux","year":"2021","unstructured":"Lheureux S, Cristea MC, Bruce JP et al (2021) Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 397(10271):281\u2013292","journal-title":"Lancet"},{"issue":"22","key":"10584_CR13","doi-asserted-by":"publisher","first-page":"9997","DOI":"10.7314\/APJCP.2014.15.22.9997","volume":"15","author":"J Li","year":"2014","unstructured":"Li J, Bian WH, Wan J et al (2014) Curdione inhibits proliferation of MCF-7 cells by inducing apoptosis[J]. Asian Pac J Cancer Prev 15(22):9997\u201310001","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"10584_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100834","volume":"13","author":"Y Liu","year":"2020","unstructured":"Liu Y, Awadia S, Delaney A et al (2020a) UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer. Transl Oncol 13(11):100834","journal-title":"Transl Oncol"},{"issue":"1","key":"10584_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12931-020-1300-y","volume":"21","author":"P Liu","year":"2020","unstructured":"Liu P, Miao K, Zhang L et al (2020b) Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-beta-induced fibroblast to myofibroblast differentiation. Respir Res 21(1):58","journal-title":"Respir Res"},{"issue":"1","key":"10584_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12931-023-02416-3","volume":"24","author":"P Liu","year":"2023","unstructured":"Liu P, Miao K, Zhang L et al (2023) Correction to: Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-beta-induced fibroblast to myofibroblast differentiation. Respir Res 24(1):114","journal-title":"Respir Res"},{"issue":"6","key":"10584_CR17","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.21873\/invivo.12155","volume":"34","author":"D Namima","year":"2020","unstructured":"Namima D, Fujihara S, Iwama H et al (2020) The effect of gemcitabine on cell cycle arrest and microRNA signatures in pancreatic cancer cells. In Vivo 34(6):3195\u20133203","journal-title":"In Vivo"},{"issue":"2","key":"10584_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.31557\/APJCP.2019.20.2.383","volume":"20","author":"A Shankar","year":"2019","unstructured":"Shankar A, Patil J, Sethi N et al (2019) Urinary dysfunction assessment in long-term survivors of carcinoma cervix using LENT SOMA Scale: an Indian Study addressing quality of life issues. Asian Pac J Cancer Prev 20(2):383\u2013389","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10584_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7314\/APJCP.2012.13.2.517","volume":"13","author":"P Suprasert","year":"2012","unstructured":"Suprasert P, Cheewakriangkrai C, Manopunya M (2012) Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma. Asian Pac J Cancer Prev 13(2):517\u2013520","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"10584_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.euo.2022.05.005","volume":"5","author":"WS Tan","year":"2022","unstructured":"Tan WS, Steinberg G, Witjes JA et al (2022) Intermediate-risk non-muscle-invasive bladder cancer: updated consensus definition and management recommendations from the International Bladder Cancer Group. Eur Urol Oncol 5(5):505\u2013516","journal-title":"Eur Urol Oncol"},{"key":"10584_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.621591","volume":"11","author":"PV Viscuse","year":"2021","unstructured":"Viscuse PV, Marques-Piubelli ML, Heberton MM et al (2021) Case report: Enfortumab Vedotin for metastatic urothelial carcinoma: a case series on the clinical and histopathologic spectrum of adverse cutaneous reactions from fatal stevens-johnson syndrome\/toxic epidermal necrolysis to dermal hypersensitivity reaction. Front Oncol 11:621591","journal-title":"Front Oncol"},{"issue":"1","key":"10584_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/cts.12893","volume":"14","author":"X Wang","year":"2021","unstructured":"Wang X, Hu J, Dong M et al (2021) DDGP vs. SMILE in relapsed\/refractory extranodal natural killer\/T-cell lymphoma, nasal type: a retrospective study of 54 patients. Clin Transl Sci 14(1):405\u2013411","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10584_CR23","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.1080\/21655979.2021.1994737","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang C, Guo J, Wu Z (2021b) Combinative treatment of Curdione and docetaxel triggers reactive oxygen species (ROS)-mediated intrinsic apoptosis of triple-negative breast cancer cells. Bioengineered 12(2):10037\u201310048","journal-title":"Bioengineered"},{"issue":"6","key":"10584_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/ERC-21-0355","volume":"29","author":"K Wang","year":"2022","unstructured":"Wang K, Schutze I, Gulde S et al (2022) Personalized drug testing in human pheochromocytoma\/paraganglioma primary cultures. Endocr Relat Cancer 29(6):285\u2013306","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"10584_CR25","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1002\/ptr.7964","volume":"37","author":"H Wang","year":"2023","unstructured":"Wang H, Xie B, Shi S et al (2023) Curdione inhibits ferroptosis in isoprenaline-induced myocardial infarction via regulating Keap1\/Trx1\/GPX4 signaling pathway. Phytother Res 37(11):5328\u20135340","journal-title":"Phytother Res"},{"issue":"2","key":"10584_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/FJC.0000000000000692","volume":"74","author":"Z Wu","year":"2019","unstructured":"Wu Z, Zai W, Chen W et al (2019) Curdione ameliorated doxorubicin-induced cardiotoxicity through suppressing oxidative stress and activating Nrf2\/HO-1 Pathway. J Cardiovasc Pharmacol 74(2):118\u2013127","journal-title":"J Cardiovasc Pharmacol"},{"key":"10584_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.740985","volume":"11","author":"Z Xie","year":"2021","unstructured":"Xie Z, Cai J, Sun W et al (2021) Development and validation of prognostic model in transitional bladder cancer based on inflammatory response-associated genes. Front Oncol 11:740985","journal-title":"Front Oncol"},{"issue":"3","key":"10584_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/ptr.6882","volume":"35","author":"F Yarmohammadi","year":"2021","unstructured":"Yarmohammadi F, Rezaee R, Karimi G (2021) Natural compounds against doxorubicin-induced cardiotoxicity: a review on the involvement of Nrf2\/ARE signaling pathway. Phytother Res 35(3):1163\u20131175","journal-title":"Phytother Res"},{"key":"10584_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154810","volume":"114","author":"P Zhao","year":"2023","unstructured":"Zhao P, Qiu J, Pan C et al (2023) Potential roles and molecular mechanisms of bioactive ingredients in Curcumae Rhizoma against breast cancer. Phytomedicine 114:154810","journal-title":"Phytomedicine"},{"issue":"8","key":"10584_CR30","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1470-2045(21)00286-2","volume":"22","author":"X Zhu","year":"2021","unstructured":"Zhu X, Cao Y, Liu W et al (2021) Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial. Lancet Oncol 22(8):1093\u20131102","journal-title":"Lancet Oncol"},{"issue":"3","key":"10584_CR31","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S1470-2045(22)00066-3","volume":"23","author":"X Zhu","year":"2022","unstructured":"Zhu X, Cao Y, Liu W et al (2022) Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial. Lancet Oncol 23(3):e105\u2013e115","journal-title":"Lancet Oncol"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10584-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-023-10584-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10584-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T14:13:24Z","timestamp":1722348804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-023-10584-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10584"],"URL":"https:\/\/doi.org\/10.1007\/s10528-023-10584-6","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}